FDA panel backs Takeda’s CMV drug for transplant patientsTakeda is closing on a first FDA approval in the treatment of refractory cytomegalovirus (CMV) infections in organ Share XFDA panel backs Takeda’s CMV drug for transplant patientshttps://pharmaphorum.com/news/fda-panel-backs-takedas-cmv-drug-for-transplant-patients/
GSK’s malaria vaccine gets WHO okay for mass rolloutThe WHO has given a green light to widespread use of GlaxoSmithKline’s malaria vaccine in Africa, in what Share XGSK’s malaria vaccine gets WHO okay for mass rollouthttps://pharmaphorum.com/news/gsks-malaria-vaccine-gets-who-okay-for-mass-rollout/
Merck preps filings for oral COVID drug, but is it really a game changer?Merck & Co is on the brink of plugging a gap in the coronavirus treatment armamentarium after its Share XMerck preps filings for oral COVID drug, but is it really a game changer?https://pharmaphorum.com/news/merck-preps-filings-for-oral-covid-drug-but-is-it-really-a-game-changer/
Pfizer ups pressure on Merck with Prevnar, flu vaccine co-dosing studyPfizer’s new Prevnar 20 conjugate pneumococcal vaccine can be dosed at the same time as the seasonal flu Share XPfizer ups pressure on Merck with Prevnar, flu vaccine co-dosing studyhttps://pharmaphorum.com/news/pfizer-ups-pressure-on-merck-with-prevnar-flu-vaccine-co-dosing-study/
Novartis drug raises hope of tackling malaria drug resistanceMore than two decades ago , Novartis made a big contribution to the fight against malaria when it Share XNovartis drug raises hope of tackling malaria drug resistancehttps://pharmaphorum.com/news/novartis-drug-raises-hope-of-tackling-malaria-drug-resistance/
Booster data backs Pfizer, Valneva Lyme disease vaccineProspects for Valneva’s COVID-19 vaccine are up in the air, but another candidate partnered with Pfizer looks increasingly Share XBooster data backs Pfizer, Valneva Lyme disease vaccinehttps://pharmaphorum.com/news/booster-data-backs-pfizer-valneva-lyme-disease-vaccine/
More malaria hope as NIH antibody protects against infectionA single dose of a monoclonal antibody developed by scientists at the US National Institutes of Health (NIH) Share XMore malaria hope as NIH antibody protects against infectionhttps://pharmaphorum.com/news/more-malaria-hope-as-antibody-protects-against-infection/
Sanofi swoops on partner Translate, buying the mRNA firm for $3.2bnSanofi has been forging ever-closer ties with its mRNA partner Translate Bio since the two started working together Share XSanofi swoops on partner Translate, buying the mRNA firm for $3.2bnhttps://pharmaphorum.com/news/sanofi-swoops-on-partner-translate-buying-the-mrna-firm-for-3-2bn/
Nestle gets closer to Seres, pledging $525m for microbiome C. diff drugSwiss food giant Nestle has firmed up its five-year-old alliance with US microbiome specialist Seres, paying $175 million Share XNestle gets closer to Seres, pledging $525m for microbiome C. diff drughttps://pharmaphorum.com/news/nestle-gets-closer-to-seres-pledging-525m-for-microbiome-c-diff-drug/
